Search Results
You are looking at 1 - 7 of 7 items for
- Author: Haiyan Wang x
- Refine by access: All content x
Search for other papers by Meijia Zhang in
Google Scholar
PubMed
Search for other papers by Haiyan Hong in
Google Scholar
PubMed
Search for other papers by Bo Zhou in
Google Scholar
PubMed
Search for other papers by Shiying Jin in
Google Scholar
PubMed
Search for other papers by Chao Wang in
Google Scholar
PubMed
Search for other papers by Maoyong Fu in
Google Scholar
PubMed
Search for other papers by Songbo Wang in
Google Scholar
PubMed
Search for other papers by Guoliang Xia in
Google Scholar
PubMed
Locally synthesized atrial natriuretic peptide (ANP) and its receptors have been found in reproductive tissues of various mammals, and play an important role in the acrosome reaction of human sperm. The objective of the present study was to examine the expression of ANP and its receptors in pig spermatozoa and oviduct, and the effect of ANP on pig spermatozoa function. The expression of ANP and its receptors was analyzed by RT-PCR. Only natriuretic peptide receptors-A (NPRA) mRNA was detected in fresh sperm. While the levels of natriuretic peptide receptors-C (NPRC) mRNA were low with no obvious change among different oviductal phases, the levels of ANP mRNA were high in oviduct(OT)1 , OT3 and OT5, but were very low in OT2. On the other hand, the levels of NPRA mRNA were low in OT1 and OT2, increased in OT3 and reached a maximum in OT4 and OT5. Western blot analysis revealed that the level of ANP was high in OT1, decreased in OT2 and OT3, and arrived at the nadir in OT4 and OT5. The effect of ANP on spermatozoa function was studied by the acrosome reaction and IVF. Incubation with ANP for 1 h significantly induced acrosome reaction of preincubated spermatozoa, and maximal response of acrosome reaction (34.1 ± 2.3%) was achieved at 1 nM ANP treatment. Both C-ANP-(4–23), a selective ligand of NPRC, and caffeine had no effect on the acrosome reaction. The stimulatory effect of ANP on acrosome reaction could be mimicked by the permeable cGMP analog, 8-Br-cGMP. ANP and caffeine had a similar effect on improving the oocytes penetration rate, polyspermy rate and the average number of sperm per penetrated oocyte. Also, ANP treatment had a similar effect on cleavage rate, blastocyst formation rate and the number of cells per blastocyst as that of caffeine treatment. The effects of ANP on the acrosome reaction and the parameters of oocyte penetration could be blocked by cGMP-dependent protein kinase (PKG) inhibitors KT5823 and/or Rp-8-pCPT-cGMPS. These results suggest that the expression of ANP in the oviduct may be involved in the regulation of the acrosome reaction and the fertilising ability of pig spermatozoa, and the PKG pathway possibly participates in the process.
Search for other papers by Caiyun Sun in
Google Scholar
PubMed
Search for other papers by Da Duan in
Google Scholar
PubMed
Search for other papers by Bo Li in
Google Scholar
PubMed
Search for other papers by Chaobin Qin in
Google Scholar
PubMed
Search for other papers by Jirong Jia in
Google Scholar
PubMed
Search for other papers by Bin Wang in
Google Scholar
PubMed
Search for other papers by Haiyan Dong in
Google Scholar
PubMed
Search for other papers by Wensheng Li in
Google Scholar
PubMed
Urotensin II (UII) is a cyclic peptide that was originally extracted from the caudal neurosecretory system (CNSS) of fish. UII is well known to exhibit cardiovascular, ventilatory, and motor effects in vertebrates. Studies have reported that UII exerts mitogenic effects and can act as an autocrine/paracrine growth factor in mammals. However, similar information in fish is limited. In this study, the full-length cDNAs of UII and its receptor (UT) were cloned and characterized in the orange-spotted grouper. UII and UT were expressed ubiquitously in various tissues in grouper, and particularly high levels were observed in the CNSS, CNS, and ovary. A functional study showed that UT was coupled with intracellular Ca2 + mobilization in HEK293 cells. Studies carried out using i.p. injections of UII in grouper showed the following: i) in the hypothalamus, UII can significantly stimulate the mRNA expression of ghrh and simultaneously inhibit the mRNA expression of somatostatin 1 (ss1) and ss2 3 h after injection; ii) in the pituitary, UII also significantly induced the mRNA expression of gh 6 and 12 h after injection; and iii) in the liver, the mRNA expression levels of ghr1/ghr2 and igf1/igf2 were markedly increased 12 and 3 h after the i.p. injection of UII respectively. These results collectively indicate that the UII/UT system may play a role in the promotion of the growth of the orange-spotted grouper.
Search for other papers by Xiuli Men in
Google Scholar
PubMed
Search for other papers by Liang Peng in
Google Scholar
PubMed
Search for other papers by Haiyan Wang in
Google Scholar
PubMed
Search for other papers by Wenjian Zhang in
Google Scholar
PubMed
Search for other papers by Shiqing Xu in
Google Scholar
PubMed
Search for other papers by Qing Fang in
Google Scholar
PubMed
Search for other papers by Honglin Liu in
Google Scholar
PubMed
Search for other papers by Wenying Yang in
Google Scholar
PubMed
Search for other papers by Jinning Lou in
Google Scholar
PubMed
The calcium-regulated transcription coactivator, Ca2 +-responsive transactivator (CREST) was expressed in pancreatic β-cells. Moreover, CREST expression became significantly increased in pancreatic islets isolated from hyperglycemic Goto–Kakizaki rats compared with normoglycemic Wistar controls. In addition, culture of β-cells in the presence of high glucose concentrations also increased CREST expression in vitro. To further investigate the role of this transactivator in the regulation of β-cell function, we established a stable β-cell line with inducible CREST expression. Hence, CREST overexpression mimicked the glucotoxic effects on insulin secretion and cell growth in β-cells. Moreover, high glucose-induced apoptosis was aggravated by upregulation of the transactivator but inhibited when CREST expression was partially silenced by siRNA technology. Further investigation found that upregulation of Bax and downregulation of Bcl2 was indeed induced by its expression, especially under high glucose conditions. In addition, as two causing factors leading to β-cell apoptosis under diabetic conditions, endoplasmic reticulum stress and high free fatty acid, mimicked the high glucose effects on CREST upregulation and generation of apoptosis in β-cells, and these effects were specifically offset by the siRNA knockdown of CREST. These results indicated that CREST is implicated in β-cell apoptosis induced by culture in high glucose and hence that CREST may become a potential pharmacological target for the prevention and treatment of type 2 diabetes mellitus.
Graduate School of Peking Union Medical College, Institute of Clinical Medical Sciences, Department of Cell Physiology and Metabolism, Beijing 100730, People's Republic of China
Search for other papers by Bo Qian in
Google Scholar
PubMed
Search for other papers by Haiyan Wang in
Google Scholar
PubMed
Search for other papers by Xiuli Men in
Google Scholar
PubMed
Search for other papers by Wenjian Zhang in
Google Scholar
PubMed
Search for other papers by Hanqing Cai in
Google Scholar
PubMed
Search for other papers by Shiqing Xu in
Google Scholar
PubMed
Search for other papers by Yaping Xu in
Google Scholar
PubMed
Search for other papers by Liya Ye in
Google Scholar
PubMed
Search for other papers by Claes B Wollheim in
Google Scholar
PubMed
Search for other papers by Jinning Lou in
Google Scholar
PubMed
We found that TRIB3, an endogenous inhibitor of Akt (PKB), is expressed in pancreatic β-cells. The TRIB3 expression is significantly increased in islets isolated from hyperglycemic Goto–Kakizaki rats compared with normal glycemic controls. In vitro high glucose treatment also resulted in increased TRIB3 expression in rat INS1 cells. To investigate the role of TRIB3 in the regulation of β-cell function, we established an INS1 stable cell line allowing inducible expression of TRIB3. We demonstrated that overexpression of TRIB3 mimicked the glucotoxic effects on insulin secretion and cell growth in INS1 cells. Moreover, induction of TRIB3 also synergistically enhanced high-glucose-elicited apoptosis in INS1 cells, whereas siRNA knock-down of TRIB3 showed the opposite effects. We also confirmed that the ΔΨm of mitochondria was decreased, caspase-3 activity was up-regulated and reactive oxygen species content was increased in TRIB3 overexpressing β cells in high glucose condition. Most interestingly, the oestrogen receptor (ER) stress inducer, thapsigargin, mimicked the high glucose effects on up-regulation of TRIB3 and generation of apoptosis in cultured INS1 cells. These effects were specifically prevented by siRNA knock down of TRIB3. We therefore conclude that TRIB3 is implicated in glucotoxicity- and ER stress-induced β-cell failure. TRIB3 could be a potential pharmacological target for prevention and treatment of type 2 diabetes.
Search for other papers by Bo Qian in
Google Scholar
PubMed
Search for other papers by Haiyan Wang in
Google Scholar
PubMed
Search for other papers by Xiuli Men in
Google Scholar
PubMed
Search for other papers by Wenjian Zhang in
Google Scholar
PubMed
Search for other papers by Hanqing Cai in
Google Scholar
PubMed
Search for other papers by Shiqing Xu in
Google Scholar
PubMed
Search for other papers by Yaping Xu in
Google Scholar
PubMed
Search for other papers by Liya Ye in
Google Scholar
PubMed
Search for other papers by Claes B Wollheim in
Google Scholar
PubMed
Search for other papers by Jinning Lou in
Google Scholar
PubMed
Search for other papers by Bo Qian in
Google Scholar
PubMed
Search for other papers by Haiyan Wang in
Google Scholar
PubMed
Search for other papers by Xiuli Men in
Google Scholar
PubMed
Search for other papers by Wenjian Zhang in
Google Scholar
PubMed
Search for other papers by Hanqing Cai in
Google Scholar
PubMed
Search for other papers by Shiqing Xu in
Google Scholar
PubMed
Search for other papers by Yaping Xu in
Google Scholar
PubMed
Search for other papers by Liya Ye in
Google Scholar
PubMed
Search for other papers by Claes B Wollheim in
Google Scholar
PubMed
Search for other papers by Jinning Lou in
Google Scholar
PubMed
Search for other papers by Qiongge Zhang in
Google Scholar
PubMed
Search for other papers by Chaoqun Wang in
Google Scholar
PubMed
Search for other papers by Yehua Tang in
Google Scholar
PubMed
Search for other papers by Qiangqiang Zhu in
Google Scholar
PubMed
Search for other papers by Yongcheng Li in
Google Scholar
PubMed
Search for other papers by Haiyan Chen in
Google Scholar
PubMed
Search for other papers by Yi Bao in
Google Scholar
PubMed
Search for other papers by Song Xue in
Google Scholar
PubMed
Search for other papers by Liangliang Sun in
Google Scholar
PubMed
Search for other papers by Wei Tang in
Google Scholar
PubMed
Search for other papers by Xiangfang Chen in
Google Scholar
PubMed
Search for other papers by Yongquan Shi in
Google Scholar
PubMed
Search for other papers by Lefeng Qu in
Google Scholar
PubMed
Search for other papers by Bin Lu in
Google Scholar
PubMed
Search for other papers by Jiaoyang Zheng in
Google Scholar
PubMed
Hyperglycemia plays a major role in the development of diabetic macrovascular complications, including atherosclerosis and restenosis, which are responsible for the most of disability and mortality in diabetic patients. Osteopontin (OPN) is an important factor involved in atherogenesis, and hyperglycemia enhances the transcriptional activity of FoxO1 which is closely association with insulin resistance and diabetes. Here, we showed that plasma OPN levels were significantly elevated in type 2 diabetic patients and positively correlated with glycated albumin (GA). The more atherosclerotic lesions were observed in the aorta of diabetic ApoE−/− mice analyzed by Sudan IV staining. High glucose increased both the mRNA and protein expression levels of OPN and inhibited the phosphorylation of FoxO1 in RAW 264.7 cells. Overexpression of WT or constitutively active mutant FoxO1 promoted the expression levels of OPN, while the dominant-negative mutant FoxO1 decreased slightly the expression of OPN. Conversely, knockdown of FoxO1 reduced the expression of OPN. Luciferase reporter assay revealed that high glucose and overexpression of FoxO1 enhanced the activities of the OPN promoter region nt −1918 ~ −713. Furthermore, the interactions between FoxO1 and the OPN promoter were confirmed by electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation assay (ChIP). Our results suggest that high glucose upregulates OPN expression via FoxO1 activation, which would play a critical role in the development of diabetic atherogenesis.
